跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
LINEZOLID KABI SOLUTION FOR INFUSION 2MG/ML
Approved
THERAPEUTIC
LINEZOLID KABI SOLUTION FOR INFUSION 2MG/ML
FRESENIUS KABI NORGE AS (NORWAY)
🇸🇬 Health Sciences Authority
Approval Date
Nov 2, 2019
Approval ID
9276d592b908392f
Company
FRESENIUS KABI NORGE AS (NORWAY)
Type
Therapeutic
Approval Details
Approval Id
9276d592b908392f
Drug Name
LINEZOLID KABI SOLUTION FOR INFUSION 2MG/ML
Product Name
LINEZOLID KABI SOLUTION FOR INFUSION 2MG/ML
Approval Number
SIN15849P
Approval Date
2019-11-02
Registrant
FRESENIUS KABI (SINGAPORE) PTE LTD
Licence Holder
FRESENIUS KABI (SINGAPORE) PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INFUSION, SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
J01XX08
Atc Item Name
linezolid
Pharma Manufacturer Name
FRESENIUS KABI (SINGAPORE) PTE LTD
Active Ingredients
Linezolid
2mg/ml
Linezolid
2mg/ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Nov 2, 2019
Approval ID
9276d592b908392f
Type
Therapeutic
Back to HSA Approvals
LINEZOLID KABI SOLUTION FOR INFUSION 2MG/ML - HSA Drug Approval Details
